141 related articles for article (PubMed ID: 22866064)
1. Pathological complete response of colorectal liver metastases following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab: A case report.
Yokota T; Sano T; Shimizu Y; Takahari D; Senda Y; Shimura M; Ura T; Shitara K; Nimura Y; Yatabe Y; Muro K
Oncol Lett; 2011 Mar; 2(2):201-205. PubMed ID: 22866064
[TBL] [Abstract][Full Text] [Related]
2. Complete remission of multiple liver metastases with only partial response of the primary rectal cancer after neoadjuvant chemotherapy.
Miura S; Ito K; Takemura N; Mihara F; Kiyomatsu T; Kokudo N
Surg Case Rep; 2020 Feb; 6(1):46. PubMed ID: 32107670
[TBL] [Abstract][Full Text] [Related]
3. Multiple liver metastases with synchronous gastric and transverse colon cancer diagnosed by gastric perforation successfully treated by SOX plus bevacizumab and completely resected by surgery: a case report.
Matsumoto R; Mori S; Kita Y; Toda H; Sasaki K; Arigami T; Matsushita D; Kurahara H; Maemura K; Natsugoe S
Surg Case Rep; 2020 Mar; 6(1):51. PubMed ID: 32180030
[TBL] [Abstract][Full Text] [Related]
4. Pathological complete response after neoadjuvant chemotherapy for rectal cancer with synchronous multiple liver metastases: a report of an unusual case.
Arata R; Itamoto T; Ikeda S; Nakahara H; Oshita A; Shinozaki K; Nishisaka T
Surg Case Rep; 2016 Dec; 2(1):106. PubMed ID: 27686666
[TBL] [Abstract][Full Text] [Related]
5. Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.
Ochiai T; Masuda T; Yagi M; Kasai R; Furuyama T; Tsukamoto K; Ito H; Igari K; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
Int Surg; 2012; 97(1):6-13. PubMed ID: 23101994
[TBL] [Abstract][Full Text] [Related]
6. A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.
Snoeren N; Voest EE; Bergman AM; Dalesio O; Verheul HM; Tollenaar RA; van der Sijp JR; Schouten SB; Rinkes IH; van Hillegersberg R
BMC Cancer; 2010 Oct; 10():545. PubMed ID: 20937118
[TBL] [Abstract][Full Text] [Related]
7. Impact of chemotherapy with S-1 and oxaliplatin (SOX) in combination with molecular-targeting agents on colorectal liver metastases.
Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
Anticancer Res; 2013 Sep; 33(9):3941-6. PubMed ID: 24023332
[TBL] [Abstract][Full Text] [Related]
8. [Clinical Response of Metastatic Colon Cancer to Chemotherapy with S-1 and Oxaliplatin - A Case Report].
Morimoto T; Yata Y; Yonenaga Y; Hanaki K; Mise M; Higaside S; Kanda Y; Noda H
Gan To Kagaku Ryoho; 2015 Jun; 42(6):743-5. PubMed ID: 26199249
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Synchronous Liver Metastasis of Ascending Colon Cancer with Pathological Complete Response to S-1/Oxaliplatin (SOX) and Bevacizumab].
Tago T; Suzuki K; Nishida K; Maruyama T; Shimazaki J; Shimoda M; Suzuki S; Kou K; Morishita Y
Gan To Kagaku Ryoho; 2018 May; 45(5):871-874. PubMed ID: 30026455
[TBL] [Abstract][Full Text] [Related]
10. Conversion surgery by hand-assisted laparoscopic surgery following chemotherapy for rectal cancer with H3 liver metastases: a case report.
Tajima T; Mukai M; Uda S; Izumi H; Yokoyama D; Hasegawa S; Makuuchi H
J Gastrointest Oncol; 2022 Oct; 13(5):2639-2646. PubMed ID: 36388681
[TBL] [Abstract][Full Text] [Related]
11. [A case of descending colon cancer with multiple liver metastases effectively treated with capecitabine/oxaliplatin (CapeOX) and bevacizumab].
Nakano M; Kameyama H; Shimada Y; Hashimoto Y; Hosoi M; Nakano M; Nogami H; Hanyu T; Takizawa K; Ishikawa T; Sakata J; Kobayashi T; Minagawa M; Kosugi S; Koyama Y; Wakai T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1785-7. PubMed ID: 25731329
[TBL] [Abstract][Full Text] [Related]
12. Pathological complete response of multiple liver metastases from colon cancer successfully treated with conversion surgery: A case report.
Kitasaki N; Abe T; Inoue M; Kohata A; Toyota K
Int J Surg Case Rep; 2023 Mar; 104():107935. PubMed ID: 36801767
[TBL] [Abstract][Full Text] [Related]
13. Completely Responsive Multiple Liver Recurrence of Colon Cancer Treated Using Chemotherapy with Oral S-1 and Oxaliplatin Plus Bevacizumab : A Case Report.
Kabashima A; Kimura K; Sanefuji K; Maekawa S
Fukuoka Igaku Zasshi; 2017 Jan; 108(1):8-13. PubMed ID: 29226661
[TBL] [Abstract][Full Text] [Related]
14. A patient who showed a pathologically complete response after undergoing treatment with XELOX plus bevacizumab for synchronous liver metastasis of grade H2 from sigmoid colon cancer.
Hisatsune Y; Nakano H; Mihara Y; Tobe N; Ishibashi K; Shimamura T; Tanaka K; Aida Y; Otsubo T
J Gastrointest Oncol; 2013 Jun; 4(2):E5-E10. PubMed ID: 23730524
[TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases.
Boilève A; De Cuyper A; Larive A; Mahjoubi L; Najdawi M; Tazdait M; Gelli M; Tselikas L; Smolenschi C; Malka D; Pignon JP; Ducreux M; Boige V
Eur J Cancer; 2020 Oct; 138():89-98. PubMed ID: 32871526
[TBL] [Abstract][Full Text] [Related]
16. Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapy.
Sperling J; Brandhorst D; Schäfer T; Ziemann C; Benz-Weißer A; Scheuer C; Kollmar O; Schilling MK; Menger MD
Clin Exp Metastasis; 2013 Apr; 30(4):447-55. PubMed ID: 23187934
[TBL] [Abstract][Full Text] [Related]
17. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
[TBL] [Abstract][Full Text] [Related]
19. Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?
Brouquet A; Overman MJ; Kopetz S; Maru DM; Loyer EM; Andreou A; Cooper A; Curley SA; Garrett CR; Abdalla EK; Vauthey JN
Cancer; 2011 Oct; 117(19):4484-92. PubMed ID: 21446046
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial.
Chen HH; Lin JK; Chen JB; Chuang CH; Liu MC; Wang JY; Changchien CR
Asia Pac J Clin Oncol; 2018 Feb; 14(1):61-68. PubMed ID: 28906589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
